Pet Biotics Market By Type (Probiotics, Prebiotics, and Postbiotics), Application (Dry, Wet, Supplements, and Snacks & Treats), Pet (Dogs, Cats, and Other Pets), Form, Function, Manufacturing Technology, and Region - Global Forecast to 2030

icon1
USD 1,232.5 MN
MARKET SIZE, 2030
icon2
CAGR 7.0%
(2025-2030)
icon3
280
REPORT PAGES
icon4
300
MARKET TABLES

OVERVIEW

pet-biotics-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The pet biotics market is projected to reach USD 1,232.5 million by 2030 from USD 878.1 million in 2025, at a CAGR of 7.0% from 2025 to 2030. The growth of the pet biotics market is driven by the rising pet humanization and preventive health focus, and growing veterinary recommendations and clinical backing.

KEY TAKEAWAYS

  • BY REGION
    The North American pet biotics market accounted for a 39.7% share in 2025.
  • BY TYPE
    By type, the postbiotic segment is expected to register a higher CAGR of 8.1%.
  • BY APPLICATION
    By application, the supplements segment is projected to grow at the highest rate from 2025 to 2030.
  • BY PET
    By pet, the dog segment is expected to dominate the market.
  • BY FORM
    By form, the dry segment is expected to hold a significant market share.
  • COMPETITIVE LANDSCAPE - KEY PLAYERS
    ADM, Alltech, and Kerry Group PLC were identified as some of the star players in the pet biotics market (global), given their strong market share and product footprint.
  • COMPETITIVE LANDSCAPE - STARTUPS
    Biotenova Sdn. Bhd., Pellucid Lifesciences Pvt. Ltd, and Verb Biotics, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

The pet biotics market is expected to grow at a rapid rate due to increasing awareness of pet health and functional nutrition, advancements in formulation and delivery technology, and rising investments by major market players.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The impact on consumers' business emerges from customer trends or disruptions. Hotbets are new, emerging types and strains of biosolutions, targeting end users who are clients of pet biotic ingredient manufacturers. Shifts, which are changing trends or disruptions, will impact the revenues of end users, thus affecting the revenues of hotspots and further the revenues of pet biotic manufacturers.

pet-biotics-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Rising pet humanization and preventive health focus
  • Growing veterinary recommendation and clinical backing
RESTRAINTS
Impact
Level
  • Heat and moisture sensitivity of microbial strains
  • Shelf-life viability concerns
OPPORTUNITIES
Impact
Level
  • Increase in pet expenditure, with a substantial increase in pet food expenditure
  • Rising demand for gut-health-focused and functional pet foods
CHALLENGES
Impact
Level
  • Supply chain complexity for live microbes
  • Competition from alternative digestive health solutions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rising pet humanization and preventive health focus

Pet owners are increasingly viewing dogs and cats as family members, leading to a significant shift in spending behavior and nutritional priorities. This “pet parent” mindset has elevated expectations for care quality, wellness, and emotional bonding — a trend similar to those observed in human health and lifestyle.

Restraint: Heat and moisture sensitivity of microbial strains

One of the major restraints in the pet biotics market is the heat and moisture sensitivity of microbial strains used as functional ingredients. The stability of probiotic microorganisms during pet food manufacturing and storage remains a major technical restraint in the market.

Opportunity: Increase in pet expenditure, with a substantial increase in pet food expenditure

The steady rise in global pet ownership has been accompanied by a significant surge in overall pet expenditure, particularly in food and nutrition categories. Pet owners increasingly view their pets as family members, prioritizing premium nutrition and health-related products over cost-based decisions.

Challenge: Supply chain complexity for live microbes

The supply chain for live microbial ingredients in the pet biotics market presents significant operational and logistical challenges. Unlike conventional feed additives, probiotic strains are biologically active and highly sensitive to environmental conditions, requiring precise handling throughout their production and distribution.

pet-biotics-market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
A&B Ingredients developed its proprietary probiotic strain PA5051 ( Pediococcus acidilactici PA5051 ) for use in both human/animal nutrition and pet food/pet supplement applications. For the pet supplement/food manufacturer: access to a differentiating probiotic ingredient with strong stability and performance claims (which supports premium positioning).
Chr. Hansen (part of Novonesis Group) expanded its microbial expertise into the pet health and nutrition market with the introduction of a new portfolio of stable live probiotics for use in pet foods and supplements. This science-based probiotic portfolio targets to meet the distinct needs of pets throughout their lifespan.
Alltech introduced MICROBUILD, a new prebiotic fiber designed to support gut health in pets by promoting beneficial microbiota and improving digestive function. This innovation reflects the growing consumer demand for functional pet nutrition, positioning Alltech to strengthen its presence in the companion animal health market with scientifically backed solutions.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The pet biotics ecosystem is categorized into manufacturers, regulatory bodies, and end-use companies. The pet biotics market is a dynamic and rapidly expanding ecosystem characterized by diverse stakeholders and innovative products. Established companies and agile startups are central to this market, and they develop pet biotic products.

pet-biotics-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

pet-biotics-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Pet Biotics Market, By Type

The probiotic segment is expected to dominate the market due to strong consumer demand for functional nutrition that supports digestive health, immunity, and overall well-being in pets.

Pet Biotics Market, By Pet

The dog segment holds a significant market share due to the increasing humanization of pets, where pet owners are more inclined to treat their dogs as family members and invest in their overall health and wellness.

Pet Biotics Market, By Form

Dry biotics, including powders, granules, and extrudable dry ingredients, are more widely adopted in commercial pet food and supplements due to their longer shelf life, higher stability, easier storage and transport, and better compatibility with processing technologies such as extrusion and baking.

Pet Biotics Market, By Application

Dry pet food application holds a significant share due to its wide adoption, ease of storage, long shelf life, and compatibility with biotic ingredients.

REGION

Asia Pacific to be fastest-growing region in global pet biotics market during the forecast period

The Asia Pacific pet biotics market is expected to register the highest CAGR during the forecast period, driven by the demand for functional pet foods that support gut health, immunity, and overall wellness of pets.

pet-biotics-market Region

pet-biotics-market: COMPANY EVALUATION MATRIX

In the pet biotics market matrix, ADM and Alltech (Star) lead with a strong market share and extensive product footprint for pets, driven by their strong geographical presence, significant formulation and distribution capabilities, and strong ties with pet food manufacturers. Orffa (Emerging Leader) is gaining visibility with its specialized pet biotic offerings for pet applications, strengthening its position through strong product offerings.

pet-biotics-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 825.2 Million
Market Forecast in 2030 (Value) USD 1,232.5 Million
Growth Rate CAGR of 7.0% from 2025 to 2030
Years Considered 2021–2030
Base Year 2024
Forecast Period 2025–2030
Units Considered Value (USD Million), Volume (Tons)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • Type:
    • probiotics
    • prebiotics
    • and postbiotics
  • Application:
    • dry food
    • wet food
    • supplements
    • and snacks & treats
  • Pet:
    • dogs
    • cats
    • and other pets
  • Form: dry and liquid
  • Functon:
    • digestive/gut health
    • immune modulation
    • metabolic & weight management
    • oral & dental health
    • other functions
  • Manufacturing Techology:
    • fermentation
    • centrifugation & filtration
    • drying & stabilization
    • encapsulation & protection
    • inactivation & cell disruption
    • formulation & blending
    • and quality control & storage
Regions Covered North America, Europe, Asia Pacific, South America, and Rest of the World
Leading Segments By type, the postbiotic segment is expected to register a higher CAGR of 8.1%.
Leading Region The North American pet biotics market accounted for a 39.7% share in 2025.
Driver Rising pet humanization and preventive health focus
Constraints Heat and moisture sensitivity of microbial strains

WHAT IS IN IT FOR YOU: pet-biotics-market REPORT CONTENT GUIDE

pet-biotics-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Europe-based Pet Food Ingredient Manufacturers
  • Detailed probiotic ingredients, competitive landscape, and competitors (financials, product portfolio) analysis
  • Customer landscape mapping by end-use sector
  • Assessment of market share and pricing analysis
  • Identified & profiled 20+ probiotic strain manufacturing companies
  • Track adoption trends in high-growth countries (US, Germany, UK, France, Brazil, China)
  • Highlight new customer clusters driven by sustainability mandates
Supplement Segment Assessment
  • Segmentation of pet probiotic supplements demand across deliverable formats such as tablets & capsules, powder, and soft chews
  • Benchmarking the adoption of various formats of supplement types across regions
  • Switching barrier analysis (quality certification, performance consistency, local regulations)
  • Revenue share for various supplement formats
  • Pinpoint substitution risks & opportunities in cost-sensitive Asia Pacific markets
  • Regulatory structure across regions

RECENT DEVELOPMENTS

  • June 2025 : ADM opened a 1,600 m², state-of-the-art R&D center at Lausanne’s biopôle campus in Switzerland to conduct pre-clinical microbiome research for pets, livestock, and aquaculture—leveraging biotics and fermentation-derived ingredients to improve gut health, immunity, digestion, and longevity. This launch reflects the booming USD 5.2 billion global animal feed biotics market (as of 2024) and growing consumer and producer demand for science-backed nutritional solutions.
  • August 2024 : Kerry announced a two-year strategic partnership with APC Microbiome Ireland at University College Cork to collaboratively research and develop novel biotic and postbiotic ingredients targeting the gut–brain axis, with the aim of improving cognitive health and mood, and a rapid market rollout following project completion.
  • July 2024 : Cargill signed an exclusive distribution agreement with Brenntag Specialties Nutrition for its postbiotic ingredient EpiCor, made from fermented baker’s yeast (Saccharomyces cerevisiae). This deal encompasses a broad range of European regions, including the UK, Ireland, France, Germany, the Nordics, the Baltics, and others. EpiCor is known for supporting immune and gut health, and this partnership aims to meet growing demand for functional health ingredients across Europe.

 

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
29
2
EXECUTIVE SUMMARY
 
 
 
 
 
34
3
PREMIUM INSIGHTS
 
 
 
 
 
39
4
MARKET OVERVIEW
Pet market thrives on humanization trends, gut-health innovations, and premium lifestyle experiences.
 
 
 
 
 
43
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
SURGE IN PET ADOPTION RATES
 
 
 
 
 
 
4.2.1.2
RISE IN PET HUMANIZATION AND FOCUS ON PREVENTIVE HEALTH
 
 
 
 
 
 
4.2.1.3
GROWING VETERINARY RECOMMENDATIONS AND CLINICAL BACKING
 
 
 
 
 
 
4.2.1.4
PREMIUMIZATION AND FUNCTIONAL FOOD TRENDS
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
HEAT AND MOISTURE SENSITIVITY OF PROBIOTIC STRAINS
 
 
 
 
 
 
4.2.2.2
SHELF-LIFE VIABILITY CONCERNS
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
INNOVATION IN INGREDIENT FORMULATION
 
 
 
 
 
 
4.2.3.2
RISING DEMAND FOR GUT-HEALTH-FOCUSED AND FUNCTIONAL PET FOODS
 
 
 
 
 
 
4.2.3.3
INCREASE IN PET EXPENDITURE WITH SUBSTANTIAL INCREASE IN PET FOOD EXPENDITURE
 
 
 
 
 
 
4.2.3.4
INCREASE IN URBAN PET LIFESTYLE EXPERIENCES: PET CAFÉS, RENTALS, AND PET-FRIENDLY TRAVEL
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
SUPPLY CHAIN COMPLEXITY FOR LIVE MICROBES
 
 
 
 
 
 
4.2.4.2
COMPETITION FROM ALTERNATIVE DIGESTIVE HEALTH SOLUTIONS
 
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
 
 
4.3.1
UNMET NEEDS IN PET BIOTICS MARKET
 
 
 
 
 
 
4.3.2
WHITE SPACE OPPORTUNITIES – SYNBIOTIC (COMBINATION OF PROBIOTICS & PREBIOTICS)
 
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
 
4.4.1
INTERCONNECTED MARKETS
 
 
 
 
 
 
4.4.2
CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
 
 
4.5.1
KEY MOVES AND STRATEGIC FOCUS
 
 
 
 
5
INDUSTRY TRENDS
Preventive pet health and eco-conscious trends redefine competitive dynamics and market opportunities.
 
 
 
 
 
56
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
THREAT OF NEW ENTRANTS
 
 
 
 
 
 
5.1.2
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.1.3
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.4
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
5.2
MACROECONOMICS OUTLOOK
 
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
 
5.2.2
SHIFT TOWARD PREVENTIVE PET HEALTH THROUGH SUPPLEMENT ADOPTION
 
 
 
 
 
 
5.2.3
EXPANSION OF PET INSURANCE COVERAGE GLOBALLY
 
 
 
 
 
 
5.2.4
ECO-CONSCIOUS PET OWNERSHIP DRIVING DEMAND FOR BIOTIC-BASED PET PRODUCTS
 
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
 
5.3.1
RESEARCH & DEVELOPMENT
 
 
 
 
 
 
5.3.2
SOURCING
 
 
 
 
 
 
5.3.3
PRODUCTION & PROCESSING
 
 
 
 
 
 
5.3.4
DISTRIBUTION
 
 
 
 
 
 
5.3.5
MARKETING & SALES
 
 
 
 
 
 
5.3.6
END USERS
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
 
5.4.1
DEMAND SIDE
 
 
 
 
 
 
5.4.2
SUPPLY SIDE
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.5.1
AVERAGE SELLING PRICE OF KEY PLAYERS, BY LIVESTOCK
 
 
 
 
 
 
5.5.2
AVERAGE SELLING PRICE TREND OF PET BIOTICS, BY REGION, 2021–2024
 
 
 
 
 
5.6
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.6.1
IMPORT SCENARIO OF HS CODE 3002
 
 
 
 
 
 
5.6.2
EXPORT SCENARIO OF HS CODE 3002
 
 
 
 
 
5.7
KEY CONFERENCES AND EVENTS, 2025–2026
 
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
 
5.9
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
 
 
5.10
CASE STUDY ANALYSIS
 
 
 
 
 
 
 
5.10.1
STABILIZED PLANT-BASED PROBIOTIC INTEGRATION BY A&B INGREDIENTS TO ENHANCE DIGESTIVE AND SKIN HEALTH IN DOGS
 
 
 
 
 
 
5.10.2
PROBIOWORLD’S DUAL-ACTION PET BIOTIC FORMULATION FOR DENTAL AND GUT HEALTH ENHANCEMENT
 
 
 
 
 
 
5.10.3
CHR. HANSEN (PART OF NOVONESIS GROUP) – PIONEERING SCIENCE-BASED PROBIOTICS PORTFOLIO FOR EVERY PET LIFE STAGE
 
 
 
 
 
5.11
IMPACT OF 2025 US TARIFF – PET BIOTICS MARKET
 
 
 
 
 
 
 
 
5.11.1
INTRODUCTION
 
 
 
 
 
 
5.11.2
KEY TARIFF RATES
 
 
 
 
 
 
5.11.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.11.4
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
 
 
5.11.4.1
US
 
 
 
 
 
 
5.11.4.2
EUROPE
 
 
 
 
 
 
5.11.4.3
ASIA PACIFIC
 
 
 
 
 
5.11.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
6
TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI-driven tech revolutionizes pet health with precision probiotics and smart fermentation monitoring.
 
 
 
 
 
76
 
6.1
TECHNOLOGY ANALYSIS
 
 
 
 
 
 
 
6.1.1
KEY TECHNOLOGIES
 
 
 
 
 
 
 
6.1.1.1
FERMENTATION
 
 
 
 
 
 
6.1.1.2
FILTRATION
 
 
 
 
 
 
6.1.1.3
FREEZE-DRYING (LYOPHILIZATION)
 
 
 
 
 
 
6.1.1.4
MICROENCAPSULATION AND NANOENCAPSULATION
 
 
 
 
 
6.1.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
6.1.2.1
IOT-BASED FERMENTATION MONITORING
 
 
 
 
 
 
6.1.2.2
ENZYMATIC HYDROLYSIS
 
 
 
 
 
6.1.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
6.1.3.1
GENOME-SCALE METABOLIC MODELING
 
 
 
 
 
 
6.1.3.2
BIOINFORMATICS
 
 
 
 
 
 
6.1.3.3
DIGITAL FERMENTATION CONTROL
 
 
 
 
 
6.1.4
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
 
 
6.1.4.1
SHORT-TERM | FOUNDATION & EARLY COMMERCIALIZATION
 
 
 
 
 
 
6.1.4.2
MID-TERM | EXPANSION & STANDARDIZATION
 
 
 
 
 
 
6.1.4.3
LONG-TERM | MASS COMMERCIALIZATION & DISRUPTION
 
 
 
 
6.2
PATENT ANALYSIS
 
 
 
 
 
 
 
6.3
FUTURE APPLICATIONS
 
 
 
 
 
 
 
6.3.1
PSYCHOBIOTICS FOR BEHAVIORAL AND COGNITIVE HEALTH IN PETS
 
 
 
 
 
 
6.3.2
SYNBIOTICS AS NEXT-GENERATION GUT HEALTH SOLUTIONS IN PETS
 
 
 
 
 
 
6.3.3
ENGINEERED/BREED-PRECISION PROBIOTIC STRAINS FOR PET HEALTH
 
 
 
 
 
 
6.3.4
MICROBIOME-LINKED DIAGNOSTIC TOOLS FOR TARGETED PET BIOTIC THERAPIES
 
 
 
 
 
 
6.3.5
SPORE-BASED PROBIOTICS FOR SHELF-STABLE, HIGH-TEMPERATURE PET FOOD PROCESSING
 
 
 
 
 
6.4
IMPACT OF GEN AI ON PET FOOD INDUSTRY
 
 
 
 
 
 
 
 
6.4.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
 
6.4.2
BEST PRACTICE OF GEN AI IN PET FOOD INDUSTRY
 
 
 
 
 
 
6.4.3
CASE STUDIES OF AI IMPLEMENTATION IN PET INDUSTRY
 
 
 
 
 
 
 
6.4.3.1
CANBIOCIN’S DATA-INTELLIGENT APPROACH TO ENHANCING FERMENTATION EFFICIENCY AND YIELD
 
 
 
 
 
 
6.4.3.2
HARMONIZING FORMULATION SYSTEMS: PPF’S PAN-EUROPEAN IMPLEMENTATION OF BESTMIX RECIPE MANAGEMENT
 
 
 
 
 
6.4.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
6.4.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PET BIOTICS
 
 
 
 
 
 
6.4.6
IMPACT OF AI/GENERATIVE AI ON PET BIOTICS MARKET
 
 
 
 
 
6.5
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
 
 
 
 
 
7
REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
Navigate future compliance with evolving global regulations and sustainability in pet biotics.
 
 
 
 
 
92
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
 
 
 
7.1.3
LABELING REQUIREMENTS AND CLAIMS
 
 
 
 
 
 
7.1.4
ANTICIPATED REGULATORY CHANGES IN NEXT 5–10 YEARS
 
 
 
 
 
 
 
7.1.4.1
MANDATORY VALIDATION OF CFU VIABILITY & FUNCTIONAL CLAIMS
 
 
 
 
 
 
7.1.4.2
GLOBAL HARMONIZATION OF PET BIOTICS INGREDIENT APPROVALS
 
 
 
 
 
 
7.1.4.3
ENHANCED SAFETY AND ANTIMICROBIAL-RESISTANCE (AMR) RISK EVALUATION
 
 
 
 
 
 
7.1.4.4
DIGITAL LABELING, DATA TRANSPARENCY, AND SMART PACKAGING REQUIREMENTS
 
 
 
 
7.2
SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
 
7.2.1
SUSTAINABLE SOURCING
 
 
 
 
 
 
7.2.2
CARBON FOOTPRINT REDUCTION INITIATIVES
 
 
 
 
 
 
7.2.3
CIRCULAR ECONOMY APPROACHES
 
 
 
 
 
7.3
IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
7.4
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
 
 
 
 
 
8
CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
Unlock profitability by understanding stakeholder influence, unmet needs, and margin opportunities in pet biotics.
 
 
 
 
 
100
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
 
 
8.2
KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
 
 
 
 
 
 
 
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
8.2.2
BUYING CRITERIA
 
 
 
 
 
8.3
ADOPTION BARRIERS AND INTERNAL CHALLENGES
 
 
 
 
 
 
8.4
UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES
 
 
 
 
 
 
8.5
MARKET PROFITABILITY
 
 
 
 
 
 
8.6
REVENUE POTENTIAL
 
 
 
 
 
 
 
8.6.1
COST DYNAMICS
 
 
 
 
 
 
8.6.2
MARGIN OPPORTUNITIES, BY INGREDIENT SOURCE
 
 
 
 
9
PET BIOTICS MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Tons | 68 Data Tables
 
 
 
 
 
108
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
PROBIOTICS
 
 
 
 
 
 
 
9.2.1
BACTERIA
 
 
 
 
 
 
 
9.2.1.1
DRIVING DIGESTIVE STRENGTH AND IMMUNE RESILIENCE IN COMPANION ANIMALS THROUGH SCIENCE-BACKED BACTERIAL PROBIOTICS
 
 
 
 
 
 
9.2.1.2
LACTOBACILLUS
 
 
 
 
 
 
9.2.1.3
BIFIDOBACTERIUM
 
 
 
 
 
 
9.2.1.4
ENTEROCOCCUS
 
 
 
 
 
 
9.2.1.5
BACILLUS
 
 
 
 
 
 
9.2.1.6
STREPTOCOCCUS THERMOPHILUS
 
 
 
 
 
9.2.2
YEAST & FUNGI
 
 
 
 
 
 
 
9.2.2.1
ADVANCED YEAST SOLUTIONS TRANSFORMING DIGESTIVE WELLNESS IN COMPANION ANIMALS
 
 
 
 
 
 
9.2.2.2
SACCHAROMYCES CEREVISIAE
 
 
 
 
 
 
9.2.2.3
SACCHAROMYCES BOULARDII
 
 
 
 
9.3
PREBIOTICS
 
 
 
 
 
 
 
9.3.1
STRENGTHENING GUT ECOLOGY FOR LONG-TERM VITALITY AND IMMUNE STRENGTH
 
 
 
 
 
 
9.3.2
OLIGOSACCHARIDES
 
 
 
 
 
 
 
9.3.2.1
FRUCTOOLIGOSACCHARIDES (FOS)
 
 
 
 
 
 
9.3.2.2
MANNANOLIGOSACCHARIDES (MOS)
 
 
 
 
 
 
9.3.2.3
GALACTOOLIGOSACCHARIDES (GOS)
 
 
 
 
 
9.3.3
INULIN
 
 
 
 
 
 
9.3.4
POLYDEXTROSE
 
 
 
 
 
 
9.3.5
OTHER PREBIOTIC TYPES
 
 
 
 
 
9.4
POSTBIOTICS
 
 
 
 
 
 
 
9.4.1
PREMIUM POSTBIOTIC SOLUTIONS DESIGNED FOR STABILITY, SAFETY, AND SUPERIOR PERFORMANCE
 
 
 
 
 
 
9.4.2
BACTERIA
 
 
 
 
 
 
 
9.4.2.1
LACTOBACILLUS
 
 
 
 
 
 
9.4.2.2
BIFIDOBACTERIUM
 
 
 
 
 
 
9.4.2.3
OTHER BACTERIA
 
 
 
 
9.5
YEAST & FUNGI
 
 
 
 
 
 
 
9.5.1
FUNCTIONAL YEAST INNOVATION SHAPING FUTURE OF PET WELLNESS
 
 
 
 
 
 
9.5.2
SACCHAROMYCES CEREVISIAE
 
 
 
 
 
 
9.5.3
SACCHAROMYCES BOULARDII
 
 
 
 
10
PET BIOTICS MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 10 Data Tables
 
 
 
 
 
139
 
10.1
INTRODUCTION
 
 
 
 
 
 
 
10.1.1
DRY FOOD
 
 
 
 
 
 
 
10.1.1.1
LONG-LASTING GUT HEALTH PROTECTION IN EVERY CRUNCHY BITE
 
 
 
 
 
10.1.2
WET FOOD
 
 
 
 
 
 
 
10.1.2.1
SMOOTH INTEGRATION, STRONGER DIGESTION—BIOTICS THAT THRIVE IN WET FORMATS
 
 
 
 
 
10.1.3
SUPPLEMENTS
 
 
 
 
 
 
 
10.1.3.1
PREMIUM SUPPLEMENT SOLUTIONS FOR PROACTIVE PET WELL-BEING
 
 
 
 
 
10.1.4
SNACKS & TREATS
 
 
 
 
 
 
 
10.1.4.1
REWARD WITH PURPOSE—TREATS ENRICHED WITH BIOTICS FOR EVERYDAY VITALITY
 
 
 
11
PET BIOTICS MARKET, BY FORM
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 6 Data Tables
 
 
 
 
 
147
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
DRY
 
 
 
 
 
 
 
11.2.1
STABLE, SCALABLE, AND SCIENCE-FORWARD—DRY BIOTICS POWERING NEXT-GENERATION PET WELLNESS
 
 
 
 
 
11.3
LIQUID
 
 
 
 
 
 
 
11.3.1
EASE OF INCORPORATION, PRECISION DOSING, AND SMOOTH DELIVERY FOR SENSITIVE AND RECOVERING PETS TO DRIVE DEMAND
 
 
 
 
12
PET BIOTICS MARKET, BY PET
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 8 Data Tables
 
 
 
 
 
152
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
DOGS
 
 
 
 
 
 
 
12.2.1
DAILY GUT AND IMMUNE SUPPORT FOR HEALTHIER, HAPPIER CANINE COMPANIONS
 
 
 
 
 
12.3
CATS
 
 
 
 
 
 
 
12.3.1
GENTLE, TARGETED GUT SUPPORT CRAFTED FOR SENSITIVE FELINE DIGESTION
 
 
 
 
 
12.4
OTHER PETS
 
 
 
 
 
13
PET BIOTICS MARKET, BY FUNCTION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 2 Data Tables
 
 
 
 
 
157
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
DIGESTIVE/GUT HEALTH
 
 
 
 
 
 
13.3
IMMUNE MODULATION
 
 
 
 
 
 
13.4
METABOLIC & WEIGHT MANAGEMENT
 
 
 
 
 
 
13.5
ORAL & DENTAL HEALTH
 
 
 
 
 
 
13.6
OTHER FUNCTIONS
 
 
 
 
 
14
PET BIOTICS MARKET, BY MANUFACTURING TECHNOLOGY
Market Size & Growth Rate Forecast Analysis
 
 
 
 
 
162
 
14.1
INTRODUCTION
 
 
 
 
 
 
14.2
FERMENTATION
 
 
 
 
 
 
14.3
CENTRIFUGATION & FILTRATION
 
 
 
 
 
 
14.4
DRYING & STABILIZATION
 
 
 
 
 
 
14.5
ENCAPSULATION & PROTECTION
 
 
 
 
 
 
14.6
INACTIVATION & CELL DISRUPTION
 
 
 
 
 
 
14.7
FORMULATION & BLENDING
 
 
 
 
 
 
14.8
QUALITY CONTROL & STORAGE
 
 
 
 
 
15
PET BIOTICS MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 14 Countries | 140 Data Tables.
 
 
 
 
 
168
 
15.1
INTRODUCTION
 
 
 
 
 
 
15.2
NORTH AMERICA
 
 
 
 
 
 
 
15.2.1
US
 
 
 
 
 
 
 
15.2.1.1
GLOBAL HUB FOR PET BIOTICS INNOVATION, POWERED BY PRESENCE OF LEADING INGREDIENT AND TECHNOLOGY COMPANIES
 
 
 
 
 
15.2.2
CANADA
 
 
 
 
 
 
 
15.2.2.1
RISING HUB FOR FUNCTIONAL PET NUTRITION AND MICROBIOME WELLNESS
 
 
 
 
 
15.2.3
MEXICO
 
 
 
 
 
 
 
15.2.3.1
RISING MARKET FOR DIGESTIVE WELLNESS AND MICROBIOME NUTRITION
 
 
 
 
15.3
EUROPE
 
 
 
 
 
 
 
15.3.1
GERMANY
 
 
 
 
 
 
 
15.3.1.1
STRONG CONSUMER DEMAND FOR PET BIOTICS TO DRIVE MARKET
 
 
 
 
 
15.3.2
UK
 
 
 
 
 
 
 
15.3.2.1
EXPANDING COMPANION-ANIMAL BASE TO DRIVE MARKET
 
 
 
 
 
15.3.3
FRANCE
 
 
 
 
 
 
 
15.3.3.1
RISING HEALTH CONCERNS TO STRENGTHEN DEMAND FOR PET BIOTICS
 
 
 
 
 
15.3.4
ITALY
 
 
 
 
 
 
 
15.3.4.1
GROWING PET HUMANIZATION AND PREMIUM NUTRITION TRENDS TO FUEL MARKET
 
 
 
 
 
15.3.5
SPAIN
 
 
 
 
 
 
 
15.3.5.1
WELLNESS-DRIVEN PET CULTURE TO ACCELERATE PET BIOTICS ADOPTION
 
 
 
 
 
15.3.6
REST OF EUROPE
 
 
 
 
 
15.4
ASIA PACIFIC
 
 
 
 
 
 
 
15.4.1
CHINA
 
 
 
 
 
 
 
15.4.1.1
RAPID URBAN GROWTH AND WELLNESS PRIORITIES TO DRIVE MARKET
 
 
 
 
 
15.4.2
JAPAN
 
 
 
 
 
 
 
15.4.2.1
HEALTH, PREMIUMIZATION, AND SUSTAINABILITY TO DRIVE DEMAND FOR PET BIOTICS
 
 
 
 
 
15.4.3
INDIA
 
 
 
 
 
 
 
15.4.3.1
CONSUMER SHIFT TOWARD FUNCTIONAL AND PREVENTIVE NUTRITION PRODUCTS TO DRIVE MARKET
 
 
 
 
 
15.4.4
AUSTRALIA & NEW ZEALAND
 
 
 
 
 
 
 
15.4.4.1
DEMAND FOR PREMIUM AND FUNCTIONAL NUTRITION TO SUPPORT MARKET GROWTH
 
 
 
 
 
15.4.5
REST OF ASIA PACIFIC
 
 
 
 
 
15.5
SOUTH AMERICA
 
 
 
 
 
 
 
15.5.1
BRAZIL
 
 
 
 
 
 
 
15.5.1.1
EXPANDING PET MARKET TO DRIVE DEMAND FOR PET BIOTICS
 
 
 
 
 
15.5.2
ARGENTINA
 
 
 
 
 
 
 
15.5.2.1
STEADY PET MARKET GROWTH TO FUEL PET BIOTICS DEMAND
 
 
 
 
 
15.5.3
REST OF SOUTH AMERICA
 
 
 
 
 
15.6
REST OF THE WORLD
 
 
 
 
 
 
 
15.6.1
MIDDLE EAST
 
 
 
 
 
 
 
15.6.1.1
RISING PET HUMANIZATION AND URBANIZATION TO FUEL DEMAND FOR PET BIOTICS
 
 
 
 
 
15.6.2
AFRICA
 
 
 
 
 
 
 
15.6.2.1
GROWING FOCUS ON PET HEALTH TO DRIVE MARKET
 
 
 
16
COMPETITIVE LANDSCAPE
Uncover market leaders' strategies and valuations to dominate the competitive landscape in 2024.
 
 
 
 
 
217
 
16.1
OVERVIEW
 
 
 
 
 
 
16.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
 
16.3
REVENUE ANALYSIS
 
 
 
 
 
 
 
16.4
MARKET SHARE ANALYSIS
 
 
 
 
 
 
 
16.5
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
 
 
 
16.5.1
COMPANY VALUATION
 
 
 
 
 
 
16.5.2
FINANCIAL METRICS
 
 
 
 
 
16.6
BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
 
16.7
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
 
 
 
 
 
 
 
 
16.7.1
STARS
 
 
 
 
 
 
16.7.2
EMERGING LEADERS
 
 
 
 
 
 
16.7.3
PERVASIVE PLAYERS
 
 
 
 
 
 
16.7.4
PARTICIPANTS
 
 
 
 
 
 
16.7.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
 
 
 
 
 
 
 
16.7.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
16.7.5.2
REGIONAL FOOTPRINT
 
 
 
 
 
 
16.7.5.3
TYPE FOOTPRINT
 
 
 
 
 
 
16.7.5.4
PET FOOTPRINT
 
 
 
 
 
 
16.7.5.5
APPLICATION FOOTPRINT
 
 
 
 
 
 
16.7.5.6
FORM FOOTPRINT
 
 
 
 
16.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
 
 
 
 
 
 
 
 
16.8.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
16.8.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
16.8.3
DYNAMIC COMPANIES
 
 
 
 
 
 
16.8.4
STARTING BLOCKS
 
 
 
 
 
 
16.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
 
 
 
 
 
16.9
COMPETITIVE SCENARIO AND TRENDS
 
 
 
 
 
 
 
16.9.1
PRODUCT LAUNCHES
 
 
 
 
 
 
16.9.2
DEALS
 
 
 
 
 
 
16.9.3
EXPANSIONS
 
 
 
 
 
 
16.9.4
OTHER DEVELOPMENTS
 
 
 
 
17
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
239
 
17.1
KEY PLAYERS
 
 
 
 
 
 
 
17.1.1
ADM
 
 
 
 
 
 
 
17.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
17.1.1.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
17.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
17.1.1.3.1
EXPANSIONS
 
 
 
 
17.1.1.4
MNM VIEW
 
 
 
 
 
 
 
 
17.1.1.4.1
KEY STRENGTHS
 
 
 
 
 
 
17.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
17.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
 
 
 
17.1.2
ALLTECH (US)
 
 
 
 
 
 
17.1.3
KERRY GROUP PLC
 
 
 
 
 
 
17.1.4
INTERNATIONAL FLAVORS & FRAGRANCES INC
 
 
 
 
 
 
17.1.5
DSM-FIRMENICH
 
 
 
 
 
 
17.1.6
CARGILL, INCORPORATED
 
 
 
 
 
 
17.1.7
PROBI
 
 
 
 
 
 
17.1.8
INGREDION (US)
 
 
 
 
 
 
17.1.9
KEMIN INDUSTRIES, INC.
 
 
 
 
 
 
17.1.10
BENEO GMBH
 
 
 
 
 
 
17.1.11
PHILEO BY LESAFFRE
 
 
 
 
 
 
17.1.12
LALLEMAND INC.
 
 
 
 
 
 
17.1.13
SACCO SYSTEM
 
 
 
 
 
 
17.1.14
SANZYME BIOLOGICS
 
 
 
 
 
 
17.1.15
ORFFA
 
 
 
 
 
17.2
STARTUPS/SMES
 
 
 
 
 
 
 
17.2.1
SYNBIO TECH INC.
 
 
 
 
 
 
17.2.2
CANBIOCIN INC.
 
 
 
 
 
 
17.2.3
BIO-CAT
 
 
 
 
 
 
17.2.4
SPECIALTY ENZYMES & PROBIOTICS
 
 
 
 
 
 
17.2.5
CREATIVE ENZYMES
 
 
 
 
 
 
17.2.6
VERB BIOTICS
 
 
 
 
 
 
17.2.7
BIOTENOVA SDN. BHD.
 
 
 
 
 
 
17.2.8
BIOPROX HEALTHCARE
 
 
 
 
 
 
17.2.9
PELLUCID LIFESCIENCES PVT. LTD
 
 
 
 
 
 
17.2.10
HOLLISON, LLC. (US)
 
 
 
 
18
RESEARCH METHODOLOGY
 
 
 
 
 
297
 
18.1
RESEARCH DATA
 
 
 
 
 
 
 
18.1.1
SECONDARY DATA
 
 
 
 
 
 
 
18.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
18.1.2
PRIMARY DATA
 
 
 
 
 
 
 
18.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
18.1.2.2
BREAKDOWN OF PRIMARY PROFILES
 
 
 
 
 
 
18.1.2.3
KEY INSIGHTS FROM INDUSTRY EXPERTS
 
 
 
 
18.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
 
18.2.1
TOP-DOWN APPROACH
 
 
 
 
 
 
18.2.2
SUPPLY-SIDE ANALYSIS
 
 
 
 
 
 
18.2.3
BOTTOM-UP APPROACH (DEMAND SIDE)
 
 
 
 
 
18.3
DATA TRIANGULATION AND MARKET BREAKUP
 
 
 
 
 
 
18.4
RESEARCH ASSUMPTIONS
 
 
 
 
 
 
18.5
RESEARCH LIMITATIONS AND RISK ASSESSMENT
 
 
 
 
 
19
ADJACENT & RELATED MARKETS
 
 
 
 
 
306
 
19.1
INTRODUCTION
 
 
 
 
 
 
19.2
STUDY LIMITATIONS
 
 
 
 
 
 
19.3
PET SUPPLEMENTS MARKET
 
 
 
 
 
 
 
19.3.1
MARKET DEFINITION
 
 
 
 
 
 
19.3.2
MARKET OVERVIEW
 
 
 
 
 
19.4
PET FOOD INGREDIENTS MARKET
 
 
 
 
 
 
 
19.4.1
MARKET DEFINITION
 
 
 
 
 
 
19.4.2
MARKET OVERVIEW
 
 
 
 
20
APPENDIX
 
 
 
 
 
309
 
20.1
DISCUSSION GUIDE
 
 
 
 
 
 
20.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
20.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
20.4
RELATED REPORTS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
USD EXCHANGE RATES, 2020–2024
 
 
 
 
 
 
TABLE 2
KEY MOVES AND STRATEGIC FOCUS
 
 
 
 
 
 
TABLE 3
IMPACT OF PORTER’S FIVE FORCES ON PET BIOTICS MARKET
 
 
 
 
 
 
TABLE 4
ROLES OF COMPANIES IN PET BIOTICS MARKET ECOSYSTEM
 
 
 
 
 
 
TABLE 5
IMPORT SCENARIO FOR HS CODE: 3002, BY COUNTRY, 2020–2024 (TONS)
 
 
 
 
 
 
TABLE 6
EXPORT SCENARIO FOR HS CODE: 3002, BY COUNTRY, 2020–2024 (TONS)
 
 
 
 
 
 
TABLE 7
PET BIOTICS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2025–2026
 
 
 
 
 
 
TABLE 8
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 9
LIST OF MAJOR PATENTS PERTAINING TO PET BIOTICS MARKET, 2020–2025
 
 
 
 
 
 
TABLE 10
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
 
TABLE 11
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
TABLE 12
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
 
 
 
 
 
 
TABLE 13
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 14
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 15
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 16
SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 17
GLOBAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 18
GLOBAL INDUSTRY STANDARDS IN PET BIOTICS MARKET
 
 
 
 
 
 
TABLE 19
LABELING REQUIREMENTS AND CLAIMS IN PET BIOTICS MARKET
 
 
 
 
 
 
TABLE 20
CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN PET BIOTICS MARKET
 
 
 
 
 
 
TABLE 21
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
 
 
 
 
 
 
TABLE 22
KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
 
 
 
 
 
 
TABLE 23
UNMET NEEDS IN PET BIOTICS MARKET, BY APPLICATION INDUSTRY (SUPPLY CHAIN)
 
 
 
 
 
 
TABLE 24
COST DYNAMICS IN PET BIOTICS MARKET
 
 
 
 
 
 
TABLE 25
MARGIN OPPORTUNITIES IN PET BIOTICS MARKET, BY INGREDIENT SOURCE
 
 
 
 
 
 
TABLE 26
PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 27
PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 28
PET BIOTICS MARKET, BY TYPE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 29
PET BIOTICS MARKET, BY TYPE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 30
PROBIOTICS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 31
PROBIOTICS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 32
PROBIOTICS: PET BIOTICS MARKET, BY REGION, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 33
PROBIOTICS: PET BIOTICS MARKET, BY REGION, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 34
PROBIOTICS: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 35
PROBIOTICS: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 36
BACTERIA: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 37
BACTERIA: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 38
BACTERIA: PET BIOTICS MARKET FOR PROBIOTICS, BY SUBTYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 39
BACTERIA: PET BIOTICS MARKET FOR PROBIOTICS, BY SUBTYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 40
LACTOBACILLUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 41
LACTOBACILLUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 42
BIFIDOBACTERIUM: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 43
BIFIDOBACTERIUM: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 44
ENTEROCOCCUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 45
ENTEROCOCCUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 46
BACILLUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 47
BACILLUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 48
STREPTOCOCCUS THERMOPHILUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 49
STREPTOCOCCUS THERMOPHILUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 50
YEAST & FUNGI: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 51
YEAST & FUNGI: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 52
YEAST & FUNGI: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 53
YEAST & FUNGI: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 54
SACCHAROMYCES CEREVISIAE: PET BIOTICS MARKET FOR YEAST & FUNGI, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 55
SACCHAROMYCES CEREVISIAE: PET BIOTICS MARKET FOR YEAST & FUNGI, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 56
SACCHAROMYCES BOULARDII: PET BIOTICS MARKET FOR YEAST & FUNGI, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 57
SACCHAROMYCES BOULARDII: PET BIOTICS MARKET FOR YEAST & FUNGI, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 58
PREBIOTICS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 59
PREBIOTICS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 60
PREBIOTICS: PET BIOTICS MARKET, BY REGION, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 61
PREBIOTICS: PET BIOTICS MARKET, BY REGION, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 62
PREBIOTICS: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 63
PREBIOTICS: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 64
OLIGOSACCHARIDES: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 65
OLIGOSACCHARIDES: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 66
OLIGOSACCHARIDES: PET BIOTICS MARKET FOR PREBIOTICS, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 67
OLIGOSACCHARIDES: PET BIOTICS MARKET FOR PREBIOTICS, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 68
FOS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 69
FOS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 70
MOS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 71
MOS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 72
GOS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 73
GOS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 74
INULIN: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 75
INULIN: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 76
POLYDEXTROSE: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 77
POLYDEXTROSE: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 78
OTHER PREBIOTICS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 79
OTHER PREBIOTICS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 80
POSTBIOTICS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 81
POSTBIOTICS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 82
POSTBIOTICS: PET BIOTICS MARKET, BY REGION, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 83
POSTBIOTICS: PET BIOTICS MARKET, BY REGION, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 84
POSTBIOTICS: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 85
POSTBIOTICS: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 86
BACTERIA: PET BIOTICS MARKET FOR POSTBIOTICS, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 87
BACTERIA: PET BIOTICS MARKET FOR POSTBIOTICS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 88
BACTERIA: PET BIOTICS MARKET FOR POSTBIOTICS, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 89
BACTERIA: PET BIOTICS MARKET FOR POSTBIOTICS, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 90
YEAST & FUNGI: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 91
YEAST & FUNGI: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 92
YEAST & FUNGI: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 93
YEAST & FUNGI: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 94
PET BIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 95
PET BIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 96
DRY FOOD: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 97
DRY FOOD: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 98
WET FOOD: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 99
WET FOOD: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 100
SUPPLEMENTS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 101
SUPPLEMENTS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 102
SNACKS & TREATS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 103
SNACKS & TREATS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 104
PET BIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 105
PET BIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 106
DRY: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 107
DRY: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 108
LIQUID: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 109
LIQUID: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 110
PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 111
PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 112
DOGS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 113
DOGS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 114
CATS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 115
CATS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 116
OTHER PETS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 117
OTHER PETS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 118
PET BIOTICS MARKET, BY FUNCTION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 119
PET BIOTICS MARKET, BY FUNCTION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 120
PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 121
PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 122
PET BIOTICS MARKET, BY REGION, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 123
PET BIOTICS MARKET, BY REGION, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 124
NORTH AMERICA: PET BIOTICS MARKET, BY COUNTRY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 125
NORTH AMERICA: PET BIOTICS MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 126
NORTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 127
NORTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 128
NORTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 129
NORTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 130
NORTH AMERICA: PET BIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 131
NORTH AMERICA: PET BIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 132
NORTH AMERICA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 133
NORTH AMERICA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 134
NORTH AMERICA: PET BIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 135
NORTH AMERICA: PET BIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 136
US: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 137
US: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 138
US: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 139
US: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 140
CANADA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 141
CANADA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 142
CANADA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 143
CANADA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 144
MEXICO: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 145
MEXICO: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 146
MEXICO: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 147
MEXICO: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 148
EUROPE: PET BIOTICS MARKET, BY COUNTRY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 149
EUROPE: PET BIOTICS MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 150
EUROPE: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 151
EUROPE: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 152
EUROPE: PET BIOTICS MARKET, BY TYPE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 153
EUROPE: PET BIOTICS MARKET, BY TYPE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 154
EUROPE: PET BIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 155
EUROPE: PET BIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 156
EUROPE: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 157
EUROPE: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 158
EUROPE: PET BIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 159
EUROPE: PET BIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 160
GERMANY: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 161
GERMANY: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 162
GERMANY: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 163
GERMANY: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 164
UK: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 165
UK: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 166
UK: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 167
UK: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 168
FRANCE: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 169
FRANCE: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 170
FRANCE: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 171
FRANCE: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 172
ITALY: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 173
ITALY: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 174
ITALY: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 175
ITALY: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 176
SPAIN: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 177
SPAIN: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 178
SPAIN: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 179
SPAIN: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 180
REST OF EUROPE: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 181
REST OF EUROPE: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 182
REST OF EUROPE: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 183
REST OF EUROPE: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 184
ASIA PACIFIC: PET BIOTICS MARKET, BY COUNTRY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 185
ASIA PACIFIC: PET BIOTICS MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 186
ASIA PACIFIC: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 187
ASIA PACIFIC: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 188
ASIA PACIFIC: PET BIOTICS MARKET, BY TYPE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 189
ASIA PACIFIC: PET BIOTICS MARKET, BY TYPE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 190
ASIA PACIFIC: PET BIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 191
ASIA PACIFIC: PET BIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 192
ASIA PACIFIC: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 193
ASIA PACIFIC: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 194
ASIA PACIFIC: PET BIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 195
ASIA PACIFIC: PET BIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 196
CHINA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 197
CHINA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 198
CHINA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 199
CHINA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 200
JAPAN: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 201
JAPAN: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 202
JAPAN: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 203
JAPAN: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 204
INDIA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 205
INDIA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 206
INDIA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 207
INDIA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 208
AUSTRALIA & NEW ZEALAND: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 209
AUSTRALIA & NEW ZEALAND: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 210
AUSTRALIA & NEW ZEALAND: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 211
AUSTRALIA & NEW ZEALAND: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 212
REST OF ASIA PACIFIC: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 213
REST OF ASIA PACIFIC: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 214
REST OF ASIA PACIFIC: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 215
REST OF ASIA PACIFIC: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 216
SOUTH AMERICA: PET BIOTICS MARKET, BY COUNTRY, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 217
SOUTH AMERICA: PET BIOTICS MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 218
SOUTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 219
SOUTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 220
SOUTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 221
SOUTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 222
SOUTH AMERICA: PET BIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 223
SOUTH AMERICA: PET BIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 224
SOUTH AMERICA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 225
SOUTH AMERICA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 226
SOUTH AMERICA: PET BIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 227
SOUTH AMERICA: PET BIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 228
BRAZIL: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 229
BRAZIL: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 230
BRAZIL: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 231
BRAZIL: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 232
ARGENTINA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 233
ARGENTINA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 234
ARGENTINA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 235
ARGENTINA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 236
REST OF SOUTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 237
REST OF SOUTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 238
REST OF SOUTH AMERICA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 239
REST OF SOUTH AMERICA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 240
REST OF THE WORLD: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 241
REST OF THE WORLD: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 242
REST OF THE WORLD: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 243
REST OF THE WORLD: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 244
REST OF THE WORLD: PET BIOTICS MARKET, BY TYPE, 2021–2024 (TONS)
 
 
 
 
 
 
TABLE 245
REST OF THE WORLD: PET BIOTICS MARKET, BY TYPE, 2025–2030 (TONS)
 
 
 
 
 
 
TABLE 246
REST OF THE WORLD: PET BIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 247
REST OF THE WORLD: PET BIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 248
REST OF THE WORLD: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 249
REST OF THE WORLD: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 250
REST OF THE WORLD: PET BIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 251
REST OF THE WORLD: PET BIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 252
MIDDLE EAST: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 253
MIDDLE EAST: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 254
MIDDLE EAST: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 255
MIDDLE EAST: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 256
AFRICA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 257
AFRICA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 258
AFRICA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 259
AFRICA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 260
OVERVIEW OF STRATEGIES ADOPTED BY KEY PET BIOTICS MARKET PLAYERS
 
 
 
 
 
 
TABLE 261
PET BIOTICS MARKET: MARKET SHARE ANALYSIS, 2024
 
 
 
 
 
 
TABLE 262
PET BIOTICS MARKET: REGIONAL FOOTPRINT, 2024
 
 
 
 
 
 
TABLE 263
PET BIOTICS MARKET: TYPE FOOTPRINT, 2024
 
 
 
 
 
 
TABLE 264
PET BIOTICS MARKET: PET FOOTPRINT, 2024
 
 
 
 
 
 
TABLE 265
PET BIOTICS MARKET: APPLICATION FOOTPRINT, 2024
 
 
 
 
 
 
TABLE 266
PET BIOTICS MARKET: FORM FOOTPRINT, 2024
 
 
 
 
 
 
TABLE 267
PET BIOTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2024
 
 
 
 
 
 
TABLE 268
PET BIOTICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
 
 
 
 
 
 
TABLE 269
PET BIOTICS MARKET: PRODUCT LAUNCHES, APRIL 2022–SEPTEMBER 2023
 
 
 
 
 
 
TABLE 270
PET BIOTICS MARKET: DEALS, JULY 2023 - OCTOBER 2025
 
 
 
 
 
 
TABLE 271
PET BIOTICS MARKET: EXPANSIONS, FEBRUARY 2020–NOVEMBER 2025
 
 
 
 
 
 
TABLE 272
PET BIOTICS MARKET: OTHER DEVELOPMENTS, NOVEMBER 2024
 
 
 
 
 
 
TABLE 273
ADM: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 274
ADM: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 275
ADM: EXPANSIONS
 
 
 
 
 
 
TABLE 276
ALLTECH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 277
ALLTECH: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 278
ALLTECH: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 279
KERRY GROUP PLC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 280
KERRY GROUP PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 281
KERRY GROUP PLC: DEALS
 
 
 
 
 
 
TABLE 282
INTERNATIONAL FLAVORS & FRAGRANCES INC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 283
INTERNATIONAL FLAVORS & FRAGRANCES INC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 284
DSM-FIRMENICH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 285
DSM-FIRMENICH: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 286
DSM-FIRMENICH: DEALS
 
 
 
 
 
 
TABLE 287
CARGILL, INCORPORATED: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 288
CARGILL, INCORPORATED: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 289
CARGILL, INCORPORATED: DEALS
 
 
 
 
 
 
TABLE 290
CARGILL, INCORPORATED: EXPANSIONS
 
 
 
 
 
 
TABLE 291
CARGILL, INCORPORATED: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 292
PROBI: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 293
PROBI: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 294
PROBI: DEALS
 
 
 
 
 
 
TABLE 295
INGREDION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 296
INGREDION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 297
KEMIN INDUSTRIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 298
KEMIN INDUSTRIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 299
BENEO GMBH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 300
BENEO GMBH: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 301
BENEO GMBH: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 302
PHILEO BY LESAFFRE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 303
PHILEO BY LESAFFRE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 304
PHILEO BY LESAFFRE (FRANCE): DEALS
 
 
 
 
 
 
TABLE 305
LALLEMAND INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 306
LALLEMAND INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 307
LALLEMAND INC.: DEALS
 
 
 
 
 
 
TABLE 308
SACCO SYSTEM: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 309
SACCO SYSTEM (ITALY): PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 310
SANZYME BIOLOGICS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 311
SANZYME BIOLOGICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 312
ORFFA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 313
ORFFA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 314
SYNBIO TECH INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 315
SYNBIO TECH INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 316
SYNBIO TECH INC.: EXPANSION
 
 
 
 
 
 
TABLE 317
CANBIOCIN INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 318
CANBIOCIN INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 319
CANBIOCIN INC.: DEALS
 
 
 
 
 
 
TABLE 320
BIO-CAT (US): COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 321
BIO-CAT: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 322
BIO-CAT: DEALS
 
 
 
 
 
 
TABLE 323
SPECIALTY ENZYMES & PROBIOTICS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 324
SPECIALTY ENZYMES & PROBIOTICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 325
SPECIALTY ENZYMES & PROBIOTICS: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 326
CREATIVE ENZYMES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 327
CREATIVE ENZYMES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 328
MARKETS ADJACENT TO PET BIOTICS MARKET
 
 
 
 
 
 
TABLE 329
PET SUPPLEMENTS MARKET, BY PET TYPE, 2021–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 330
PET SUPPLEMENTS MARKET, BY PET TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 331
PET FOOD INGREDIENTS MARKET, BY FORM, 2019–2022 (USD MILLION)
 
 
 
 
 
 
TABLE 332
PET FOOD INGREDIENTS MARKET, BY FORM, 2023–2028 (USD MILLION)
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
MARKET SCENARIO
 
 
 
 
 
 
FIGURE 2
GLOBAL PET BIOTICS MARKET, 2021-2030
 
 
 
 
 
 
FIGURE 3
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PET BIOTICS MARKET (2020–2025)
 
 
 
 
 
 
FIGURE 4
DISRUPTIONS INFLUENCING GROWTH OF PET BIOTICS MARKET
 
 
 
 
 
 
FIGURE 5
HIGH-GROWTH SEGMENTS IN PET BIOTICS MARKET, 2025-2030
 
 
 
 
 
 
FIGURE 6
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN PET BIOTICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 7
RISING PET HUMANIZATION AND PREVENTIVE HEALTH FOCUS CREATE LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS
 
 
 
 
 
 
FIGURE 8
DOGS SEGMENT AND NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARES IN 2025
 
 
 
 
 
 
FIGURE 9
PROBIOTICS SEGMENT TO DOMINATE MARKET IN 2025
 
 
 
 
 
 
FIGURE 10
DOGS SEGMENT TO LEAD MARKET IN 2025
 
 
 
 
 
 
FIGURE 11
DRY FOOD SEGMENT TO DOMINATE MARKET IN 2025
 
 
 
 
 
 
FIGURE 12
DRY FORM TO DOMINATE MARKET IN 2025
 
 
 
 
 
 
FIGURE 13
US TO DOMINATE MARKET
 
 
 
 
 
 
FIGURE 14
PET BIOTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 15
US: EXPENDITURE IN PET INDUSTRY, 2020–2024 (USD BILLION)
 
 
 
 
 
 
FIGURE 16
PET BIOTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 17
INGREDIENTS MOST FREQUENTLY PERCEIVED TO HAVE HEALTH BENEFITS
 
 
 
 
 
 
FIGURE 18
PERCENTAGE INCREASE YEAR OVER YEAR AND COMBINED NUMBER OF PETS IN US
 
 
 
 
 
 
FIGURE 20
PET BIOTICS MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 21
AVERAGE SELLING PRICE OF KEY PLAYERS, BY APPLICATION, 2025 (USD)
 
 
 
 
 
 
FIGURE 22
AVERAGE SELLING PRICE TREND OF PET BIOTICS, BY REGION, 2021–2024 (USD/TON)
 
 
 
 
 
 
FIGURE 23
IMPORT OF HS CODE 3002, BY KEY COUNTRY, 2020–2024 (TONS)
 
 
 
 
 
 
FIGURE 24
EXPORT OF HS CODE 3002, BY KEY COUNTRY, 2020–2024 (TONS)
 
 
 
 
 
 
FIGURE 25
TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS
 
 
 
 
 
 
FIGURE 26
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
 
 
FIGURE 29
FUTURE APPLICATIONS
 
 
 
 
 
 
FIGURE 31
PET BIOTICS MARKET DECISION-MAKING FACTORS
 
 
 
 
 
 
FIGURE 32
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR THREE APPLICATIONS
 
 
 
 
 
 
FIGURE 33
KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
 
 
 
 
 
 
FIGURE 34
ADOPTION BARRIERS AND INTERNAL CHALLENGES
 
 
 
 
 
 
FIGURE 36
PET BIOTICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 37
PET BIOTICS MARKET, BY FORM, 2025 VS. 2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 38
PET BIOTICS MARKET, BY PET, 2025 VS. 2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 40
CHINA TO RECORD FASTEST GROWTH DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 41
NORTH AMERICA: PET BIOTICS MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 42
ASIA PACIFIC: PET BIOTICS MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 43
REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024 (USD BILLION)
 
 
 
 
 
 
FIGURE 44
MARKET SHARE ANALYSIS, 2024
 
 
 
 
 
 
FIGURE 45
COMPANY VALUATION FOR MAJOR PLAYERS IN PET BIOTICS MARKET, 2025
 
 
 
 
 
 
FIGURE 46
EV/EBITDA OF MAJOR PLAYERS, 2025
 
 
 
 
 
 
FIGURE 47
PET BIOTICS MARKET: BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
FIGURE 48
PET BIOTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
 
 
 
 
 
 
FIGURE 49
PET BIOTICS MARKET: COMPANY FOOTPRINT, 2024
 
 
 
 
 
 
FIGURE 50
PET BIOTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
 
 
 
 
 
 
FIGURE 51
ADM: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 52
KERRY GROUP PLC: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 53
INTERNATIONAL FLAVORS & FRAGRANCES INC: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 54
DSM-FIRMENICH: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 55
CARGILL, INCORPORATED: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 56
PROBI: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 57
INGREDION: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 58
PET BIOTICS MARKET: RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 59
BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
 
 
FIGURE 60
MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 61
SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP
 
 
 
 
 
 
FIGURE 62
PET BIOTICS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
 
 
 
 
 
 
FIGURE 63
DATA TRIANGULATION
 
 
 
 
 
 

Methodology

This study employed two primary approaches to estimate the current size of the pet biotics market. Exhaustive secondary research was conducted to gather information on the type, application, pet, form, function, and manufacturing technology segments of the market (qualitative). The next step involved validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, data triangulation was used to estimate the market size of segments and subsegments.

Secondary Research

This research study utilized extensive secondary sources, including directories and databases such as Bloomberg Businessweek and Factiva, to identify and collect information for a technical, market-oriented, and commercial market study. In the secondary research process, sources such as annual reports, press releases & investor presentations of companies, white papers, pet food journals, certified publications, articles from recognized authors, directories, and databases were referred to identify and collect information. Secondary research was mainly used to obtain key information about the industry’s supply chain, the pool of key players, and market classification and segmentation based on the industry trends to the bottom-most level, regional markets, and key developments from market- and technology-oriented perspectives.

Primary Research

Extensive primary research was conducted after obtaining information regarding the pet biotics market scenario through secondary research. Several primary interviews were conducted with market experts from the demand and supply sides across major countries of North America, Europe, Asia Pacific, South America, and the Rest of the World. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief Experience Officers (CXOs), vice presidents (VPs), directors from business development, marketing, research, and development teams, as well as key executives from distributors and key opinion leaders.

Primary interviews were conducted to gather insights, including market statistics, revenue data from products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped to understand the various trends related to type, application, pet, form, functions, and manufacturing technology (qualitative), as well as region. Stakeholders from the demand side, including distributors, importers, exporters, and end-use sectors such as pet food and pet supplement manufacturers, were interviewed to gain insight into the buyers’ perspective on suppliers, products, and the outlook for their businesses, which will impact the overall market.

Pet Biotics Market
 Size, and Share

The three tiers of the companies are defined based on their total revenues in 2023 or 2024, based on the availability of financial data: Tier 1: Revenue > USD 1 billion; Tier 2: USD 100 million ≤ revenue ≤ USD 1 billion; Tier 3: Revenue < USD 100 million.

RoW includes Africa and the Middle East.

COMPANY NAME

DESIGNATION

Cargill, Incorporated (US)

Product Development Manager

Bharat International Pet Foods Pvt. Ltd. (Manager)

Sales Manager

Purina Animal Nutrition LLC (US)

Marketing Head

BIOPROX (France)

Marketing Head

Alltech (US)

Senior Sales Manager

Kemin Industries, Inc. (US)

Business Development Manager

 

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches were used to estimate and validate the total size of the pet biotics market. These approaches were also used extensively to determine the size of various market segments. The research methodology used to estimate the market size includes the following details:

  • The key players in the industry and the overall markets were identified through extensive secondary research.
  • All shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
  • All possible parameters that affect the market covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain final quantitative and qualitative data.
  • The research included the study of reports, reviews, and newsletters of top market players, along with extensive interviews for opinions from leaders, such as CEOs, directors, and marketing executives.

Pet Biotics Market : Top-Down and Bottom-Up Approach

Pet Biotics Market  Top Down and Bottom Up Approach

Data Triangulation

After determining the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. The data triangulation procedure was employed, wherever applicable, to estimate the overall pet biotics market and obtain precise statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. The market size was also validated using the top-down and bottom-up approaches.

Market Definition

Pet biotics refer to a group of functional ingredients, including probiotics, prebiotics, and postbiotics, that are incorporated into pet foods, treats, toppers, and nutritional supplements to support gut health, digestion, immunity, nutrient absorption, and overall well-being. Probiotics are live beneficial microorganisms, prebiotics are non-digestible fibers that selectively nourish these beneficial microbes, and postbiotics are bioactive compounds produced through microbial fermentation. Together, these ingredients help maintain a balanced gut microbiome and enhance the health and performance of pets.

Key Stakeholders

  • Probiotic strain manufacturers
  • Prebiotics & postbiotics ingredient manufacturers
  • Pet food and supplement product manufacturers
  • Key companies engaged in pet food processing
  • Intermediate stakeholders, including distributors, retailers, associations, regulatory bodies, and others
  • Government organizations, institutes, and research organizations
  • Associations and industry bodies:
    • Pet Food Institute (PFI)
    • International Probiotics Association (IPA)
    • International Scientific Association for Probiotics and Prebiotics (ISAPP)
    • European Food Safety Authority (EFSA)
    • American Pet Products Association
    • Global Alliance of Pet Food Associations
    • The European Pet Organization
    • Association of American Feed Control Officials (AAFCO)
    • American Veterinary Medical Association (AVMA)

Report Objectives

  • To determine and project the size of the pet biotics market based on type, application, pet, form, function, manufacturing technology (qualitative), and region, over five years, ranging from 2025 to 2030
  • To identify the attractive opportunities in the market by determining the largest and fastest-growing segments across regions
  • To provide detailed information about the key factors influencing market growth (drivers, restraints, opportunities, and challenges)
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To analyze the micromarkets with respect to individual growth trends, prospects, and their contribution to the total market
  • To identify and profile the key players in the market
  • To understand the competitive landscape and identify the major growth strategies adopted by players across the key regions

Customization Options

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which provides a detailed comparison of each company's product portfolio.

Geographic Analysis

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

  • Further breakdown of the Rest of European pet biotics market into key countries
  • Further breakdown of the Rest of Asia Pacific pet biotics market into key countries
  • Further breakdown of the Rest of South American pet biotics market into key countries

Company Information

  • Detailed analyses and profiling of additional market players (up to five)

 

 

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Pet Biotics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Pet Biotics Market

DMCA.com Protection Status